Skip to Main Content

Paper Details

Stage II/III Rectal Cancer Post-Treatment Surveillance Patterns of Care: A SEER- Medicare Study.
Adv Res Gastroenterol Hepatol
0
2021
CEA, Stage II/III Rectal Cancer, carcinoembryonic antigen, patient, patients, rectal cancer, stage II/III
Author NameAffiliation
Charles F LynchUniversity of Iowa College of Public Health
Charles F LynchIowa Cancer Registry, University of Iowa College of Public Health
Elizabeth A ChrischillesUniversity of Iowa College of Public Health
Mary E CharltonUniversity of Iowa College of Public Health
Mary E CharltonIowa Cancer Registry, University of Iowa College of Public Health
  • 1 - 5

Datasets

Release 1.2